• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield

    6/4/26 10:06:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email

    PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ:HCAT). Vitalware's platform and domain expertise will strengthen Med-Metrix's mid-revenue cycle offering, improving charge capture and coding accuracy, which is expected to help drive measurable improvement in net revenue yield for Med-Metrix's clients.

    Med-Metrix

    The transaction will augment Med-Metrix's technology-enabled revenue cycle platform and supports its strategy of combining operator-led services with scalable software solutions. Vitalware's leadership team and employees are expected to be integrated into Med-Metrix's operations following the acquisition, further enhancing Med-Metrix's ability to deliver end-to-end solutions across the revenue cycle. The transaction is subject to customary closing conditions.

    Vitalware's cloud-based solutions enhance performance across chargemaster management, revenue integrity, price transparency, and coding workflows – critical functions that directly impact reimbursement accuracy and financial performance. The combination will enable Med-Metrix to better support its expanding health system client base in identifying revenue leakage, strengthening compliance, and optimizing net patient revenue.

    Founded in 2011 and acquired by Health Catalyst in 2020, Vitalware is a recognized leader in mid-revenue cycle software solutions, with its 5-Time Best in KLAS chargemaster management platform and tools supporting charge capture and regulatory compliance. Its solutions are widely used across hospitals and health systems to improve visibility and continuity in coding, billing, and revenue integrity processes.

    "I am very excited to welcome Vitalware to Med-Metrix and build on their strong foundation in revenue integrity," said Joseph Davi, Founder and CEO of Med-Metrix. "This acquisition expands our ability to deliver measurable financial outcomes by combining differentiated technology with deep operational expertise across the mid-revenue cycle."

    "Vitalware represents a natural extension of our platform," said Rob Wright, Co-President of Med-Metrix. "By integrating their impressive software capabilities, we are better positioned to help providers improve reimbursement accuracy, manage compliance risk, and capture the full value of care delivered."

    "The Vitalware team has built a great business through years of dedication and commitment, and we are grateful for everything they gave to Health Catalyst," said Ben Albert, CEO of Health Catalyst. "This strategic move opens our next phase, and we have found a tremendous partner in Med-Metrix to take Vitalware forward."

    "We are pleased to support Med-Metrix in this strategic acquisition," said Lucas Rogers, Partner at Harvest Partners. "Vitalware will enhance the Company's mid-revenue cycle capabilities, positioning Med-Metrix to continue executing on its growth strategy through a combination of organic initiatives and targeted acquisitions."

    About Med-Metrix

    Med-Metrix is a leading technology-enabled services platform providing end-to-end Revenue Cycle Management (RCM) and Business Intelligence solutions for health systems and physician groups across the United States. The Company combines proprietary technology with deep operational expertise to drive measurable financial and operational outcomes.

    About Vitalware

    Vitalware provides cloud-based software solutions focused on revenue integrity, chargemaster management, pricing transparency, and coding optimization. Its platform helps healthcare organizations improve compliance, enhance charge capture, and optimize financial performance across the mid-revenue cycle. Founded in 2011, Vitalware was acquired by Health Catalyst in 2020 and has been widely adopted by hospitals and health systems nationwide.

    About Harvest Partners

    Founded in 1981, Harvest Partners is an established private equity firm with over 40 years of experience investing in middle-market companies and partnering with high-quality management teams to build growing businesses. The firm invests in service-oriented business across four core sectors: business services & industrials, commercial services, consumer services and healthcare services. This strategy leverages Harvest Partners' multi-decade experience in financing organic and acquisition-oriented growth opportunities. The firm has ~$20 billion in assets under management as of December 31, 2025. For more information, please visit www.harvestpartners.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/med-metrix-enters-into-definitive-agreement-to-acquire-vitalware-to-enhance-coding-accuracy-and-net-revenue-yield-302791688.html

    SOURCE Med-Metrix, LLC

    Get the next $HCAT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    3/18/2026$1.00Overweight → Equal Weight
    Wells Fargo
    8/27/2025$4.00Overweight → Neutral
    Piper Sandler
    8/11/2025Buy → Neutral
    Citigroup
    8/8/2025$4.00Overweight → Neutral
    Cantor Fitzgerald
    6/17/2025Buy → Neutral
    BTIG Research
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Health Catalyst downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Health Catalyst from Overweight to Equal Weight and set a new price target of $1.00

    3/18/26 8:20:46 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00

    8/27/25 8:19:35 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Citigroup

    Citigroup downgraded Health Catalyst from Buy to Neutral

    8/11/25 9:56:17 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield

    PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ:HCAT). Vitalware's platform and domain expertise will strengthen Med-Metrix's mid-revenue cycle offering, improving charge capture and coding accuracy, which is expected to help drive measurable improvement in net revenue yield for Med-Metrix's clients. The transaction will augment Med-Metrix's technology-enable

    6/4/26 10:06:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation

    SALT LAKE CITY, June 04, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT) today announced it has signed a definitive agreement to divest Vitalware, LLC and the Vitalware business unit, its mid-revenue cycle business, to Med-Metrix for a total consideration of $147 million in cash. This divestiture sharpens Health Catalyst's focus on driving measurable improvement for health systems across cost, clinical, and consumer performance, and the Company expects it to accelerate the broader transformation underway. "This is a big step forward for Health Catalyst. We are concentrating our business around the areas where we have the deepest conviction,

    6/4/26 9:03:29 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports First Quarter 2026 Results

    SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. "We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed t

    5/11/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Albert Benjamin covered exercise/tax liability with 336 shares, decreasing direct ownership by 0.02% to 1,458,456 units (SEC Form 4) to satisfy withholding obligation

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    6/3/26 7:46:49 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Chief People Officer Llewelyn Linda covered exercise/tax liability with 8,519 shares, decreasing direct ownership by 3% to 321,132 units (SEC Form 4) to cover taxes

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    6/3/26 7:46:28 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Alger Jason covered exercise/tax liability with 18,804 shares, decreasing direct ownership by 3% to 722,840 units (SEC Form 4) (for withholding tax)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    6/3/26 7:45:28 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    SEC Filings

    View All

    Health Catalyst Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    6/4/26 9:10:13 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form DEFA14A filed by Health Catalyst Inc

    DEFA14A - Health Catalyst, Inc. (0001636422) (Filer)

    6/3/26 5:23:42 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form DEF 14A filed by Health Catalyst Inc

    DEF 14A - Health Catalyst, Inc. (0001636422) (Filer)

    6/3/26 4:11:37 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    2/27/24 4:01:39 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 7:51:57 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Health Catalyst Inc

    SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 4:44:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/12/24 3:55:05 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    View All

    Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors

    SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Steve Nelson, Executive Vice President and President of Aetna, a CVS Health company, has been appointed to its Board of Directors, effective May 1, 2026.  Nelson's appointment follows the naming of Ben Albert as CEO and Justin Spencer as Chairman of the Board earlier this year, continuing a deliberate pattern of leadership moves designed to accelerate the company's transformation– executing on a single, coordinated strategy to help health systems address cost, cli

    4/30/26 9:27:50 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Appoints Ben Albert as Chief Executive Officer

    Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc. (NASDAQ:HCAT) ("Health Catalyst" or the "Company"), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert, the Company's President and Chief Operating Officer (COO), was appointed to serve as Chief Executive Officer (CEO) and as a member of Health Catalyst's Board of Directors ( "Board"), effective February 12, 2026.

    2/18/26 8:55:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors

    SALT LAKE CITY, Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr. Arens collectively o

    12/2/25 6:59:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Financials

    Live finance-specific insights

    View All

    Health Catalyst Reports First Quarter 2026 Results

    SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. "We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed t

    5/11/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

    SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ126." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    5/1/26 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports Fourth Quarter and Year End 2025 Results

    SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025. "We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million," said Ben Albert, CEO of Health Catalyst "In 2026, we are focused on the future and on positioning Health Catalyst for long‑term success. As I continue to assess the business, I see both meaningful opportunities and clear areas where we must improve. I am confident in the

    3/12/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology